SCHEMBL10175470

SCHEMBL10175470

COC(=O)C(OC(C)(C)C)c1c(C)nc2c(C)c(-c3ccccc3)nn2c1Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 1/20 0.39
▸ NR1I2 O75469 1/20 0.36
▸ ADORA3 P0DMS8 2/20 0.35
▸ LMNA P02545 1/20 0.35
▸ THRB P10828 1/20 0.35
▸ SMN1; SMN2 Q16637 3/20 0.34
▸ RECQL P46063 2/20 0.34
▸ NPSR1 Q6W5P4 2/20 0.34
▸ SLC34A1 Q06495 1/20 0.34
▸ KMT2A Q03164 2/20 0.33
▸ AKT1 P31749 1/20 0.33
▸ AKT2 P31751 1/20 0.33
▸ KDM4E B2RXH2 2/20 0.32
▸ ALDH1A1 P00352 2/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ RXFP1 Q9HBX9 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL462578 0.90 SMN1; SMN2 (0.41) CYP3A4NR1I2ADORA3LMNATHRB
SCHEMBL461920 0.83 CYP3A4 (0.44) CYP3A4NR1I2THRB
SCHEMBL458296 0.82 KDM4E (0.46) LMNASMN1; SMN2KMT2AKDM4EALDH1A1
SCHEMBL470322 0.82 PDE4A (0.39) CYP3A4ADORA3LMNANPSR1KMT2A
SCHEMBL461035 0.81 NR1I2 (0.48) NR1I2THRBSMN1; SMN2KDM4EALDH1A1
SCHEMBL15226886 0.81 NR1I2 (0.48) NR1I2THRBSMN1; SMN2KDM4EALDH1A1
SCHEMBL457945 0.80 CYP3A4 (0.31) CYP3A4
SCHEMBL15235302 0.77 NR1I2 (0.45) NR1I2THRBSMN1; SMN2KDM4EALDH1A1
SCHEMBL462362 0.76 GPR119 (0.43) CYP3A4NPSR1KMT2AKDM4EALDH1A1
SCHEMBL15226964 0.75 NPC1 (0.47) NR1I2SMN1; SMN2KDM4EALDH1A1RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012033735-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-15 — — WO disclosed
Send feedback